Skip to content

4Accepted Feb 28, 7:45 AM ET

Bjarke Henric Bjorn 4

INZYInozyme Pharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

7:45 AM

Feb 28, 2022

Filed

Feb 28, 2022

Documents

1

Size

5.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.